Pharmacology, Toxicology and Pharmaceutical Science
Surgical Infection
100%
Infection
86%
Antiinfective Agent
84%
Hospital Infection
80%
Bloodstream Infection
67%
Carbon Dioxide
63%
HIV
63%
Methicillin-Resistant Staphylococcus Aureus
58%
Cohort Study
57%
Urinary Tract Infection
51%
Device Infection
45%
Staphylococcus Aureus
43%
Infectious Agent
41%
Observational Study
40%
Antibiotics
39%
Prevalence
36%
Sepsis
34%
Ventilator Associated Pneumonia
33%
Antibiotic Therapy
30%
Methicillin Resistant Staphylococcus Aureus Infection
30%
Catheter Infection
28%
Vancomycin
28%
Fungus Spore
27%
Measles
27%
Disease
27%
Infection Rate
27%
Healthcare Associated Infection
26%
Acinetobacter Baumannii
25%
Septic Shock
25%
Adverse Event
25%
Live Attenuated Influenza Vaccine
24%
Acquired Immune Deficiency Syndrome
22%
Immune Deficiency
21%
Human Immunodeficiency Virus Infection
20%
Influenza Vaccine
20%
Hospital Mortality
20%
Normal Human
19%
Penicillium oxalicum
19%
Clinical Study
18%
Bacterial Spore
18%
Staphylococcal Bacteremia
18%
Acute Hepatitis A
18%
Hepatitis A Virus
18%
Lung Tuberculosis
18%
Prospective Cohort Study
18%
Bacillus Cereus
18%
Inflammatory Arthritis
18%
Opportunistic Infection
18%
Etanercept
18%
Rheumatoid Arthritis
18%
Medicine and Dentistry
Surgical Infection
100%
Surveillance System
79%
Infection
66%
Human Immunodeficiency Virus
63%
Hospital Infection
60%
Stomach Surgery
54%
Antiinfective Agent
54%
Acquired Immune Deficiency Syndrome
50%
Cohort Analysis
49%
Bloodstream Infection
46%
Sepsis
45%
Immunogenicity
45%
Urinary Tract Infection
45%
Septic Shock
38%
Peptoclostridium difficile
36%
Middle East Respiratory Syndrome
36%
Observational Study
32%
Infection Rate
31%
Human Immunodeficiency Virus Infection
29%
Immune Response
29%
Antiretroviral Therapy
27%
Adverse Event
26%
Disease
25%
Methicillin Resistant Staphylococcus Aureus
25%
Antibiotics
23%
Odds Ratio
23%
Acinetobacter Baumannii
23%
Hospital Mortality
23%
Outpatient
21%
Antibiotic Therapy
21%
Healthcare Associated Infection
20%
Awareness
19%
Non-Hodgkin Lymphoma
19%
Hazard Ratio
18%
Device Infection
18%
Ventilator-Associated Pneumonia
18%
Antibiotic-Associated Diarrhea
18%
Opportunistic Infection
18%
Colitis
18%
Factor Analysis
18%
Prospective Cohort Study
18%
Patient with Human Immunodeficiency Virus
18%
Middle East Respiratory Syndrome Coronavirus
18%
Immune Deficiency
18%
Rheumatoid Arthritis
18%
Multidrug Resistant Tuberculosis
18%
Polysaccharide Vaccine
18%
Patient Isolation
18%
Influenza Vaccine
18%
Serotype
18%
Nursing and Health Professions
Intensive Care Unit
80%
Hospital Infection
54%
Ventilator-Associated Pneumonia
51%
Antimicrobial Stewardship
46%
Device Infection
45%
Sepsis
43%
Septic Shock
43%
Confidence Interval
42%
Health Care Personnel
37%
Antiinfective Agent
37%
Lung Tuberculosis
36%
Prevalence
35%
Urinary Tract Infection
33%
Catheter Infection
30%
Hospital Mortality
29%
Cohort Analysis
28%
University Hospital
28%
Surgical Infection
27%
Infection
26%
Antibiotic Therapy
25%
Antiretroviral Therapy
25%
Healthcare Associated Infection
24%
Methicillin-Resistant Staphylococcus Aureus
24%
Odds Ratio
22%
Immune Deficiency
21%
Bloodstream Infection
21%
Hazard Ratio
18%
Catheter
18%
Pilot Study
18%
Outpatient
18%
Measles Antibody
18%
Hepatitis A
18%
Acute Hepatitis A
18%
Acquired Immune Deficiency Syndrome
18%
Patient Isolation
18%
Human Immunodeficiency Virus
18%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Measles
18%
Vaccine Hesitancy
18%
Vaccination Coverage
18%
Mortality Rate
16%
Infection Rate
14%
Disease
14%
Blood Transfusion
13%
Practice Guideline
12%
Health Center
10%
Surgical Intensive Care Unit
10%
Pharmaceutical Care
10%
Teaching Hospital
10%
Multivariate Analysis
9%
